| Roles of proteoglycans and glycosaminoglycans in wound healing and fibrosis S Ghatak, EV Maytin, JA Mack, VC Hascall, I Atanelishvili, ... International journal of cell biology 2015, 2015 | 199 | 2015 |
| Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis S Ghatak, VC Hascall, RR Markwald, C Feghali-Bostwick, CM Artlett, ... Journal of Biological Chemistry 292 (25), 10490-10519, 2017 | 82 | 2017 |
| Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease S Ghatak, GS Bogatkevich, I Atnelishvili, T Akter, C Feghali-Bostwick, ... Journal of Biological Chemistry 289 (11), 7856-7872, 2014 | 48 | 2014 |
| Utilization of glycosaminoglycans/proteoglycans as carriers for targeted therapy delivery S Misra, VC Hascall, I Atanelishvili, R Moreno Rodriguez, RR Markwald, ... International journal of cell biology 2015, 2015 | 34 | 2015 |
| Thrombin Increases Lung Fibroblast Survival while Promoting Alveolar Epithelial Cell Apoptosis via the Endoplasmic Reticulum Stress Marker, CCAAT Enhancer–Binding Homologous … I Atanelishvili, J Liang, T Akter, DD Spyropoulos, RM Silver, ... American journal of respiratory cell and molecular biology 50 (5), 893-902, 2014 | 21 | 2014 |
| Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease I Atanelishvili, T Akter, A Noguchi, O Vuyiv, L Wollin, RM Silver, ... Clin Exp Rheumatol 37 (Suppl 119), S115-24, 2019 | 18 | 2019 |
| Safety and Tolerability of Thrombin Inhibition in Scleroderma‐Associated Interstitial Lung Disease RM Silver, DA Wilson, T Akter, I Atanelishvili, JT Huggins, K Kajdasz, ... ACR open rheumatology 1 (7), 403-411, 2019 | 17 | 2019 |
| Differential DNA methylation landscape in skin fibroblasts from African Americans with systemic sclerosis DA Baker Frost, W da Silveira, ES Hazard, I Atanelishvili, RC Wilson, ... Genes 12 (2), 129, 2021 | 13 | 2021 |
| M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo I Atanelishvili, Y Shirai, T Akter, T Buckner, A Noguchi, RM Silver, ... Translational Research 170, 99-111, 2016 | 12 | 2016 |
| Establishment of an indirect ELISA for detection of the novel antifibrotic peptide M10 T Akter, I Atanelishvili, A Noguchi, RM Silver, GS Bogatkevich PloS one 12 (11), e0188588, 2017 | 8 | 2017 |
| Safety and suitability of a direct thrombin inhibitor, dabigatran etexilate, in scleroderma-associated interstitial lung disease (SSc-ILD) patients R Silver, I Atanelishvili, T Akter, K Kajdasz, D Wilson, P Nietert, ... A21. CLINICAL AND MECHANISTIC STUDIES OF LUNG FIBROSIS, A1055-A1055, 2018 | 7 | 2018 |
| D1398G variant of MET is associated with impaired signaling of hepatocyte growth factor in alveolar epithelial cells and lung fibroblasts I Atanelishvili, Y Shirai, T Akter, A Noguchi, KT Ash, S Misra, S Ghatak, ... PloS one 11 (9), e0162357, 2016 | 5 | 2016 |
| Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma‐Associated Lung Fibrosis GS Bogatkevich, I Atanelishvili, AM Bogatkevich, RM Silver Arthritis & Rheumatology 75 (3), 438-448, 2023 | 4* | 2023 |
| IQGAP1 mediates α-smooth muscle actin expression and enhances contractility of lung fibroblasts T Akter, I Atanelishvili, Y Shirai, A Garcia-Martos, RM Silver, ... Rheumatology (Sunnyvale) 8 (242), 2161-1149.1000242, 2018 | 3 | 2018 |
| D1398G Variant Of Hepatocyte Growth Factor Receptor-A Potential Biomarker Of Severe Interstitial Lung Disease In African American Scleroderma Patients. I Atanelishvili, T Akter, RM Silver, GS Bogatkevich ARTHRITIS AND RHEUMATISM 65, S1247-S1247, 2013 | 2 | 2013 |
| Nintedanib inhibits contractile activity of lung myofibroblasts in a cellular model of scleroderma associated pulmonary fibrosis G Bogatkevich, I Atanelishvili, T Akter, L Wollin, RM Silver European Respiratory Journal 52 (suppl 62), 2018 | 1 | 2018 |
| M10, a Caspase Cleavage Product of the Hepatocyte Growth Factor Receptor, Downregulates Bone Morphogenetic Protein-9-Induced Smad1/5/8 Phosphorylation and Collagen Production … A Noguchi, I Atanelishvili, T Akter, RM Silver, GS Bogatkevich Arthritis & Rheumatology 69, 2017 | 1 | 2017 |
| Anti-Fibrotic Effects of a Newly Discovered HGF Receptor Carboxy-Terminal Fragment in Systemic Sclerosis. Y Shirai, I Atanelishvili, T Akter, R Silver, G Bogatkevich ARTHRITIS & RHEUMATOLOGY 66, S1313-S1313, 2014 | 1 | 2014 |
| Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease GS Bogatkevich, KB Highland, T Akter, PJ Nietert, I Atanelishvili, ... Systemic Sclerosis-An Update on the Aberrant Immune System and Clinical Features, 2012 | 1 | 2012 |
| Evaluation of Efficacy, Immunogenicity, and Toxicity of a Novel Drug Candidate for Scleroderma-associated Interstitial Lung Disease G Bogatkevich, I Atanelishvili, CB Perry, R Silver ARTHRITIS & RHEUMATOLOGY 74, 2324-2325, 2022 | | 2022 |
moreno-rodriguez raAssistant ProfessorVerified email at musc.edu
